{"id":14873,"date":"2023-12-05T08:38:41","date_gmt":"2023-12-05T07:38:41","guid":{"rendered":"https:\/\/www.bio-sistemak.eus\/biosistemak-starts-its-participation-in-the-european-jacardi-project-to-tackle-cardiovascular-diseases-and-diabetes\/"},"modified":"2023-12-05T08:40:06","modified_gmt":"2023-12-05T07:40:06","slug":"biosistemak-starts-its-participation-in-the-european-jacardi-project-to-tackle-cardiovascular-diseases-and-diabetes","status":"publish","type":"post","link":"https:\/\/www.bio-sistemak.eus\/en\/biosistemak-starts-its-participation-in-the-european-jacardi-project-to-tackle-cardiovascular-diseases-and-diabetes\/","title":{"rendered":"Biosistemak starts its participation in the European JACARDI project to tackle cardiovascular diseases and diabetes"},"content":{"rendered":"

\"\"<\/a>Biosistemak <\/strong>is one of the organisations participating in the new European Union Joint Action on Cardiovascular Diseases and Diabetes (JACARDI) <\/strong>which aims to reduce the impact of cardiovascular diseases and diabetes, and the associated risk factors, both at individual and population level.<\/p>\n

Officially launched on 1 November 2023, JACARDI <\/strong>will run for four years and will involve ministries of health, public health agencies, non-governmental organisations, universities and research institutes. The project launch meeting was held in Rome (Italy) from 27-29 November 2023, and was attended by more than 200 people.<\/p>\n

This project aims to address cardiovascular diseases (CVD), which remain the leading cause of death in the EU, affecting 63 million people, and the prevalence of diabetes, which has increased dramatically in adults to 32.3 million in the last decade. These chronic diseases pose a major threat to people’s health and well-being while compromising health systems and hampering countries’ social and economic development.<\/p>\n

An unprecedented coordinated European initiative <\/strong><\/span><\/p>\n

JACARDI <\/strong>emerges as a unified European response to the growing challenge of CVD and diabetes. The project will implement best practices for the treatment and management of these diseases in different European contexts through the execution of 142 pilot projects, supported by a common methodology for implementation and evaluation.<\/p>\n

The project is coordinated by the Italian National Institute of Health (ISS) and has received co-financing of 53 million euros from the European Commission. The consortium is made up of 76 partners from 21 European countries, including Ukraine, and will involve more than 300 public health experts, including the Biosistemak research team <\/strong>representing the Basque Country with the collaboration of Osakidetza.<\/p>\n

JACARDI <\/strong>will test and deliver solutions and tools for the management of CVD and diabetes, including prevention, early detection, treatment, care and self-management of the diseases to achieve the following objectives:<\/p>\n